Biodexa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1487.9%.

Top 25 shareholders own 40.88% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.83%	Brio Capital L.P.	57,114	€262.4k	167%	10.02%
8.12%	Cavalry Fund I Management, LLC	47,193	€216.8k	1.1%	66.82%
7.24%	Ionic Ventures, LLC	42,080	€193.3k	141%	no data
3.1%	Iroquois Capital Management, LLC	18,000	€82.7k	0%	3.23%
2.48%	GS Capital Partners LLC	14,385	€66.1k	128%	no data
2.44%	Bukwang Pharmaceutical Co., Ltd.	14,177	€65.1k	0%	no data
2.44%	Melior Pharmaceuticals, Inc	14,177	€65.1k	0%	no data
1.53%	Bigger Capital, LLC	8,911	€40.9k	0%	0.33%
1.47%	District 2 Capital LP	8,523	€39.2k	0%	0.6%
0.95%	Mercer Street Capital Partners, LLC	5,542	€25.5k	13.5%	22.41%
0.25%	Virtu Financial LLC, Asset Management Arm	1,431	€6.6k	0%	no data
0.23%	Citadel Advisors LLC	1,337	€6.1k	0%	no data
0.21%	Susquehanna International Group, LLP, Asset Management Arm	1,204	€5.5k	0%	no data
0.17%	Armistice Capital LLC	998	€4.6k	0%	no data
0.14%	Two Sigma Securities, LLC, Asset Management Arm	822	€3.8k	0%	no data
0.083%	Haitong International Asset Management (HK) Ltd.	482	€2.2k	0%	no data
0.069%	UBS Asset Management AG	399	€1.8k	311%	no data
0.045%	Shamir Capital	262	€1.2k	0%	0.06%
0.041%	Rhumbline Advisers Ltd Partnership	241	€1.1k	123%	no data
0.0093%	Anson Group	54	€248.2	0%	no data
0.0069%	Contravisory Investment Management, Inc.	40	€183.9	0%	no data
0.0059%	Bank of America Corporation, Asset Management Arm	34	€156.1	-83.7%	no data
0.0043%	A&B (HK) Company Limited	25	€114.8	0%	no data
0.0029%	Walleye Capital LLC	17	€78.2	0%	no data
0.0019%	GAMMA Investing LLC	11	€50.4	-92.9%	no data